Canada markets closed

Microbix Biosystems Inc. (MBX.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.3200-0.0050 (-1.54%)
At close: 02:40PM EDT

Microbix Biosystems Inc.

265 Watline Avenue
Mississauga, ON L4Z 1P3
905 361 8910

Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Cameron L. GroomePresident, CEO & Director416.65kN/AN/A
Mr. James S. CurrieChief Financial Officer266.51kN/AN/A
Dr. Kenneth Hughes Ph.D.Chief Operating Officer266.57kN/AN/A
Dr. Mark Luscher Ph.D.Senior Vice President of Scientific Affairs249.29kN/AN/A
Mr. Philip CasselliSenior Vice President of Sales, Business Development & Marketing265.1kN/AN/A
Mr. Christopher B. LobbCompliance Officer, General Counsel & SecretaryN/AN/AN/A
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.


Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

Corporate Governance

Microbix Biosystems Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.